atypical endometrial hyperplasia
atypical endometrial hyperplasia
Explore linked clinical trials. Standard reference: MONDO:000609616 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Endometrial Cancer Vaginal Fluid Specimen Collection Study | Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Hemorrhage, Metrorrhagia, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, Uterine Hemorrhage, atypical endometrial hyperplasia, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, precancerous condition, uterine disorder | Active, not recruiting | Not stated | 2026-10-05 | NCT07544680 | |
| Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer | Adnexal Diseases, Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, atypical endometrial hyperplasia, cervix disorder, dysplasia of cervix, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, precancerous condition, uterine disorder | Recruiting | Not stated | 2026-09-29 | NCT05051722 | |
| GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients | Body Weight, Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, atypical endometrial hyperplasia, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, nutritional disorder, obesity disorder, overnutrition, progesterone resistance, uterine disorder | Recruiting | Phase 2 / Phase 3 | 2026-09-10 | NCT06379113 | |
| GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients | Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, atypical endometrial hyperplasia, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, progesterone resistance, uterine disorder | Recruiting | Phase 2 / Phase 3 | 2026-09-10 | NCT05316935 | |
| Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer | Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, atypical endometrial hyperplasia, female reproductive system disorder, uterine disorder | Active, not recruiting | Phase 2 | 2026-09-10 | NCT02397083 | |
| Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer | Body Weight, Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, atypical endometrial hyperplasia, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, nutritional disorder, obesity disorder, overnutrition, uterine disorder | Not yet recruiting | Phase 2 | 2026-08-24 | NCT07781150 | |
| Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia | Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, atypical endometrial hyperplasia, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Not yet recruiting | Phase 2 | 2026-07-20 | NCT07714070 | |
| SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer | Body Weight, Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, atypical endometrial hyperplasia, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, nutritional disorder, obesity disorder, overnutrition, uterine disorder | Not yet recruiting | Phase 4 | 2026-06-10 | NCT07462663 | |
| Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia | Body Weight, Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, atypical endometrial hyperplasia, female reproductive system disorder, infertility disorder, nutritional disorder, obesity disorder, overnutrition, uterine disorder | Recruiting | Phase 2 / Phase 3 | 2026-06-04 | NCT05316493 | |
| Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy | Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, atypical endometrial hyperplasia, endometrial carcinoma, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Active, not recruiting | Phase 2 | 2026-06-03 | NCT03671811 | |
| Intrauterine Injection of Type III Collage in FST of EC/AEH | Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, atypical endometrial hyperplasia, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Phase 2 | 2026-03-30 | NCT07377734 | |
| Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer | Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, atypical endometrial hyperplasia, female reproductive system disorder, uterine disorder | Active, not recruiting | Phase 2 | 2025-08-15 | NCT00788671 | |
| GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients | Body Weight, Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, atypical endometrial hyperplasia, female reproductive system disorder, nutritional disorder, obesity disorder, overnutrition, progesterone resistance, uterine disorder | Active, not recruiting | Phase 2 / Phase 3 | 2025-08-11 | NCT06390904 | |
| Ultrasound and Histology in AEH and Early EEC Treated Conservatively | Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, atypical endometrial hyperplasia, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Not yet recruiting | Not stated | 2025-06-19 | NCT07028242 | |
| Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer | Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, atypical endometrial hyperplasia, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Not stated | 2025-05-04 | NCT05647109 | |
| Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC | Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, atypical endometrial hyperplasia, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Phase 2 / Phase 3 | 2021-09-13 | NCT03463252 |